Increased glycolysis promotes tumor-associated MDSC expansion in the NPC microenvironment by triggering the activation of p65 and the NLRP3 inflammasome signaling pathway, which leads to the production of IL-1β, IL6 and GM-CSF by malignant NPC cells (Fig 7). The gene discussed is NLRP3; the disease is neoplasm.